Skip to main content
Clinical Trials/NCT06168097
NCT06168097
Active, not recruiting
Not Applicable

MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis

Asian Institute of Gastroenterology, India1 site in 1 country200 target enrollmentNovember 15, 2023
ConditionsEndometriosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometriosis
Sponsor
Asian Institute of Gastroenterology, India
Enrollment
200
Locations
1
Primary Endpoint
2. To understand the function of candidate predictive miRNAs for endometriosis by investigating their downstream targets and associated biological pathways
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

OBJECTIVES :

  1. To investigate the expression pattern of miRNAs operational in inflammation, angiogenesis, hypoxia, apoptosis and cell proliferation in eutopic and ectopic endometrium of patients with endometriosis and normal endometrium of healthy controls.
  2. To understand the function of candidate predictive miRNAs for endometriosis by investigating their downstream targets and associated biological pathways.
  3. Evaluation of significant outcome of objective 1 in serum samples to establish them as biomarkers.

Study Design:

Case control study. sample size: 200

Detailed Description

METHODOLOGY : 1 Investigator will take Both blood and tissue samples used to study them. 2. Investigator will take approximately 3 ml of blood which will be used from the blood sample collected for routine preoperative tests (Surgical profile) before their planned surgery. 3.Small tissue samples will be taken from the tissue which is surgically excised as a part of treatment. 4. It will include tissue from inner lining of uterus (endometrium) in all participants and from excised endometriosis tissue in patients with endometriosis.

Registry
clinicaltrials.gov
Start Date
November 15, 2023
End Date
December 15, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Asian Institute of Gastroenterology, India
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients having more severe forms of endometriosis (Stage III and IV)
  • The probands were chosen randomly from the pool of available endometriosis patients and healthy controls of Indian origin.

Exclusion Criteria

  • Diagnosis of non-endometriotic ovarian cysts, adenomyosis, ovarian cancer, fibroids, and stage I and II endometriosis.
  • Exclusion criteria defined for the control group were personal history of chronic pelvic pain, secondary dysmenorrhea, abnormal uterine bleeding and family history of endometriosis.

Outcomes

Primary Outcomes

2. To understand the function of candidate predictive miRNAs for endometriosis by investigating their downstream targets and associated biological pathways

Time Frame: 3 years

ROC curve analysis is to estimate the sensitivity and specificity of miRNA expression levels to establish them as biomarkers for endometriosis.

Secondary Outcomes

  • To investigate the expression pattern of miRNAs and their downstream targets in endometrial tissues (samples of normal adult endometrium and ectopic and eutopic endometrium of patients with endometriosis)(3 years)

Study Sites (1)

Loading locations...

Similar Trials